healthcare stocks

VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill based expertise with emerging technologies for the healthcare industry, announced today as a part of its expansion plans, the Company is now formally entering the cannabis clinic space.

https://stockprice.com/sponsored-content/multi-trillion-dollar-industry-providing-massive-opportunity-in-2019-beyond-2019-01-02/

The recent acquisition of Cloud Practice has provided an underlying platform to help empower and streamline patient-doctor interaction. “We are currently working on a partnership model to hard code the decision-making process into the Electronic Medical Records (EMR),” said Dr. Essam Hamza, CEO of Premier. “There has been a critical gap between the patient’s need for medical cannabis and the doctor’s knowledge and comfort level in prescribing it. At Premier we understand the frustration felt from both the patient and the doctor and are integrating what we think is a revolutionary process. This new tool will allow us to provide a much-needed service to the 287 clinics and almost 3 million patients in our ecosystem.”

Much of the traditionally labor-intensive process of onboarding patients will now be done automatically with Premier’s smart EMR. The doctor will just need to identify patients with conditions that could warrant medical cannabis consideration and the integrated technology will assess the patient’s data, and through the use of analytics, output a comprehensive recommendation along with links to corresponding medical research specific to the diagnosis. Thus, providing essential education and guidance to doctors enabling them to make informed decisions on medical cannabis qualification, dosing and prescriptions.

Additionally, the Company has been in discussions with a short list of Canadian Licensed Producers (LP) under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in order to partner with a, or multiple, LP(s) to provide doctor and patient education at the clinic level.

The company expects to provide additional updates on its expansion later in Q1 2019.

ON BEHALF OF THE BOARD OF DIRECTORS

“Dr. Essam Hamza, MD”
Chief Executive Officer

About Premier Health

Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are developing innovative health care approaches that combine human skill-based expertise with emerging technologies, with the goal of setting the gold standard for services in locations of interest worldwide. Premier Health’s subsidiary, HealthVue is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have an ecosystem of over 100,000 active patients and have plans to rapidly increase that number both domestically and internationally. The HealthVue team has a strong track record of successfully creating value in healthcare and technology enterprises. The Management team has deep clinical, financial and operational expertise and a passion for improving healthcare for all patients.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FOR ADDITIONAL INFORMATION CONTACT:

Premier Health Group Inc.
www.mypremierhealth.com
Email: investors@mypremierhealth.com

DISCLAIMER: Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. FULL DISCLAIMER HERE

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tiziana Life Sciences (TLSA) Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma

NEW YORK–(BUSINESS WIRE)– Tiziana Life Sciences plc (TLSA), a biotechnology company focusing…

Premier Health (OTC:P​HGRF) (CSE:P​HGI) Signs LOI with NexTech AR Solutions to Explore Healthcare Applications of Augmented Reality Technology

VANCOUVER, British Columbia, March 6, 2019 (GLOBE NEWSWIRE) — Premier Health Group…